Melissa Lumish
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| 68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC) (NCT06852820) | Melissa Lumish | 2026-06-01 |
| Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma (NCT06044311) | Melissa Lumish | 2024-09-30 |
Track Melissa Lumish automatically
Every clearance here is in the API, with alerts when new ones post.